Activity of trovafloxacin against blood isolates ofStreptococcus pneumoniae in Sweden
- 1 August 1996
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 15 (8) , 671-675
- https://doi.org/10.1007/bf01691157
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- In vitro activity of the new fluoroquinolone CP-99,219Antimicrobial Agents and Chemotherapy, 1994
- In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobialDiagnostic Microbiology and Infectious Disease, 1994
- Antimicrobial susceotibilirv of bacterial isolates in South Sweden including a 13‐year follow‐up study of some respiratory tract pathogensAPMIS, 1994
- In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1993
- In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridoneAntimicrobial Agents and Chemotherapy, 1993
- Antimicrobial Resistance in Streptococcus pneumoniae: An OverviewClinical Infectious Diseases, 1992
- Trends in Antimicrobial Resistance of Clinical Isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990)Clinical Infectious Diseases, 1992
- Intercontinental Spread of a Multiresistant Clone of Serotype 23F Streptococcus pneumoniaeThe Journal of Infectious Diseases, 1991
- Evaluation of in vitro antibacterial activity of enoxacin: Comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limitsDiagnostic Microbiology and Infectious Disease, 1985
- In vitro and in vivo activity of DL-8280, a new oxazine derivativeAntimicrobial Agents and Chemotherapy, 1982